文献速递衰弱、肌少症与跌倒老年慢病共病管理

依那普利长期治疗减轻衰老小鼠衰弱并性别差异调节炎症因子

Chronic Treatment With the ACE Inhibitor Enalapril Attenuates the Development of Frailty and Differentially Modifies Pro- and Anti-inflammatory Cytokines in Aging Male and Female C57BL/6 Mice.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2019-01-01

本研究在中年和老年雌雄C57BL/6小鼠中纵向评估ACE抑制剂依那普利对衰弱指数的影响。依那普利(30 mg/kg/天饲料给药)减轻了中年和老年雌鼠及老年雄鼠的衰弱,且对血压无长期影响。治疗还性别特异性地降低老年雌鼠促炎因子并升高老年雄鼠抗炎因子IL-10。

要点

  • 依那普利减轻中年和老年雌鼠及老年雄鼠的衰弱指数。
  • 依那普利对小鼠血压无长期影响。
  • 依那普利性别特异性地调节促炎和抗炎细胞因子。

核心结论

  • 依那普利长期治疗可减轻衰老小鼠的衰弱,即使晚年起始也有 preclinical 证据支持。

研究设计与样本

  • 纵向研究,使用临床衰弱指数评估中年(9-13月龄)和老年(16-25月龄)C57BL/6小鼠。
  • 依那普利以30 mg/kg/天剂量加入饲料长期给药。

主要发现

  • 依那普利减轻中年和老年雌鼠及老年雄鼠的衰弱,对血压无长期影响。
  • 老年雌鼠促炎因子IL-1α、MCP-1和MIP-1a降低,老年雄鼠抗炎因子IL-10升高。

临床怎么用

  • 提供临床前证据提示依那普利可能延迟衰弱发生,但尚不能直接推导至人类老年医学科临床决策。

局限性

  • 研究为小鼠临床前实验,结果不能直接外推至人类。
  • 原文未报告样本量、P值或置信区间等详细统计信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Studies on interventions that can delay or treat frailty in humans are limited. There is evidence of beneficial effects of angiotensin converting enzyme (ACE) inhibitors on aspects related to frailty, such as physical function, even in those without cardiovascular disease. This study aimed to longitudinally investigate the effect of an ACE inhibitor on frailty in aging male and female mice. Frailty was assessed with a clinical frailty index (FI) which quantifies health-related deficits in middle-aged (9-13 months) and older (16-25 months) mice. Chronic treatment with enalapril (30 mg/kg/day in feed) attenuated frailty in middle-aged and older female mice, and older male mice, without a long-term effect on blood pressure. Enalapril treatment resulted in a reduction in the proinflammatory cytokines interleukin (IL)-1α, monocyte chemoattractant protein-1 and macrophage inflammatory protein-1a in older female mice, and an increase in the anti-inflammatory cytokine IL-10 in older male mice compared with control animals. These sex-specific effects on inflammation may contribute to the protective effects of enalapril against frailty. This is the first study to examine the longitudinal effect of an intervention on the FI in mice, and provides preclinical evidence that enalapril may delay the onset of frailty, even when started later in life.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Keller K, Kane A, Heinze-Milne S, et al. Chronic Treatment With the ACE Inhibitor Enalapril Attenuates the Development of Frailty and Differentially Modifies Pro- and Anti-inflammatory Cytokines in Aging Male and Female C57BL/6 Mice. J Gerontol A Biol Sci Med Sci. 2019. PMID: 30256910. doi:10.1093/gerona/gly219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。